KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 162 filers reported holding KURA ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $9,838,000 | -10.2% | 525,262 | 0.0% | 0.44% | -6.8% |
Q2 2021 | $10,952,000 | -26.2% | 525,262 | 0.0% | 0.47% | -9.2% |
Q1 2021 | $14,849,000 | -13.4% | 525,262 | 0.0% | 0.52% | -31.9% |
Q4 2020 | $17,155,000 | -46.7% | 525,262 | -50.0% | 0.77% | -58.8% |
Q3 2020 | $32,172,000 | +88.0% | 1,050,000 | 0.0% | 1.86% | +51.5% |
Q2 2020 | $17,115,000 | – | 1,050,000 | – | 1.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |